Rating History for Trius Therapeutics (TSRX) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for TSRX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/31/2013 N/A Downgrade Neutral
(Overweight)		 N/A
(N/A)		 11.71
(13.63)		 16.4% Details